Coronaviruses have caused devastation in both human and animal populations, affecting both health and the economy. Amidst the emergence and re-emergence of coronaviruses, humans need to surmount the health and economic threat of coronaviruses through science and evidence-based approaches. One of these approaches is through biotechnology, particularly the heterologous production of biopharmaceutical proteins. This review article briefly describes the genome, general virion morphology, and key structural proteins of different coronaviruses affecting animals and humans. In addition, this review paper also presents the different systems in recombinant protein technology such as bacteria, yeasts, plants, mammalian cells, and insect/insect cells systems used to express key structural proteins in the development of countermeasures such as diagnostics, prophylaxis, and therapeutics in the challenging era of coronaviruses.

This scoping review evaluates the role of vector-associated dissemination in contaminating the Philippine food supply chain with antimicrobial-resistant (AMR) Salmonella, an emerging infectious disease threat, using a One Health perspective to map the mechanisms through which insects and rodents bridge environmental reservoirs to human food systems. This scoping review was conducted and reported in accordance with the PRISMA-ScR guidelines. From 1969 records identified through systematic database searches, 52 studies met the inclusion criteria. These comprised 21 primary Philippine studies, 28 non-Philippine studies (including ASEAN-based historical baseline reports), and 3 policy/gray literature studies, prioritized to reflect tropical ecological and agricultural settings. Results suggest that intensive swine and poultry farming may contribute to the emergence of multidrug resistance (MDR) linked to genes such as bla_TEM and qnr. Evidence suggests that Salmonella persists in environmental matrices, such as manure and irrigation water, and that synanthropic vectors, including Rattus rattus and various fly species, potentially serve as biological and mechanical bridges in transmission. Clinical data reveal an alarming trend toward invasive non-typhoidal salmonellosis (iNTS) showing reduced susceptibility to cephalosporins and fluoroquinolones. Despite these findings, major evidence gaps remain, particularly regarding the prevalence of vector-borne Salmonella in pre-harvest produce. Consequently, mitigation requires a One Health framework that integrates non-antibiotic interventions, pest management to disrupt transmission pathways, and rapid diagnostic tools, such as loop-mediated isothermal amplification (LAMP), to enhance market surveillance.

The global tilapia industry is threatened due to the mass die-off of farmed tilapia caused by an emerging virus, Tilapia Lake Virus (TiLV). The threat of TiLV disease demands for cost-effective diagnostics and preventive measures such as protein and antibody-based detection tools and even vaccines like protein subunit vaccines. In this study, we aimed to recombinantly express the entire S4 protein of TiLV in vitro and in vivo using an extended host-range baculovirus expression vector system (EHR-BEVS) and used the purified protein to generate polyclonal anti-S4 antibodies. The parental extended host-range ABM-eIF4E baculovirus previously developed in our laboratory was used to generate the recombinant ABM-eIF4E-S4-His baculovirus expression vector using homologous recombination and was purified through multiple rounds of plaque selection and end-point titration, eliminating the need for the use of antibiotic resistance gene selection marker. Different insect cell lines including Trichoplusia ni Hübner, 1802 larvae were infected with ABM-eIF4-S4-His to produce recombinant S4 protein. Western blotting was used to detect the recombinantly expressed S4 protein. We generated an antibiotic resistance gene-free EHR-BEV and observed the permissibility of all the insect cell lines tested including T. ni larvae to infection with the recombinant ABM-eIF4E-S4-His. Secondly, immunogenic S4 protein capable of eliciting rabbit polyclonal anti-S4 antibodies was recombinantly expressed in the infected insect cells and larvae. TiLV S4 protein was recombinantly expressed in vitro and in vivo using extended host-range ABM-eIF4E-S4-His baculovirus expression vector and was shown to induce rabbit antibody production that can recognize S4 protein supporting the potential of insect larvae as alternative biofactories in the production of recombinant TiLV protein subunit for the development of diagnostics and preventive vaccines against TiLV disease.